Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer

We present a study to evaluate the feasibility and clinical utility of amplicon‐based Oncomine Pan‐Cancer cell‐free assay to detect circulating tumor DNA (ctDNA) in patients with early or advanced breast cancer. In this study, 109 early and metastatic breast cancer patients were recruited before the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Yoon Ming, Takahashi, Yoko, Chan, Hiu Ting, Otaki, Masumi, Fujishima, Makoto, Shibayama, Tomoko, Miki, Yoshio, Ueno, Takayuki, Nakamura, Yusuke, Low, Siew‐Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Genetics, Genomics, and Proteomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780051/
https://www.ncbi.nlm.nih.gov/pubmed/33075187
http://dx.doi.org/10.1111/cas.14697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780051/
https://www.ncbi.nlm.nih.gov/pubmed/33075187
http://dx.doi.org/10.1111/cas.14697

Ejemplares similares